Suchergebnisse - "Molina, Francisco"

PubPharm (16)

1

The Role of Cell Cycle Arrest Biomarkers for Predicting Acute Kidney Injury in Critically Ill COVID-19 Patients : A Multicenter, Observational Study

enthalten in: Critical care medicine | 2023

von Weiss, R. | von Groote, T. | Ostermann, M. | +23

2

"Acute kidney injury in critically ill patients with COVID-19 : The AKICOV multicenter study in Catalonia"

enthalten in: PloS one | 2023

von Sánchez, A. | Pérez, A. | Pérez-Carrasco, M. | +18

ErratumIn: PLoS One. 2023 Dec 7;18(12):e0295778. - PMID 38060539

3

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults : results from the REJUVENATE study

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Cornely, O. | Cisneros, J. | Torre-Cisneros, J. | +37

4

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X) : a randomised, placebo-controlled trial

enthalten in: Lancet (London, England) | 2020

von Deodhar, A. | van der Heijde, D. | Gensler, L. | +115

CommentIn: Lancet. 2020 Jan 4;395(10217):6-8. - PMID 31813638

5

Multicentric study on total pancreatectomies

enthalten in: Cirugia espanola | 2019

von Ramia, J. | Martin-Perez, E. | Poves, I. | +92

6

Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis : 48-Week Results from a Randomized Phase III Trial

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2019

von Suh, C. | Yoo, D. | Berrocal Kasay, A. | +23

7

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis : a randomized controlled Phase 3 trial

enthalten in: mAbs | 2018

von Park, W. | Božić-Majstorović, L. | Milakovic, D. | +24

8

Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis : Results up to Week 72 of a Phase I Randomized Controlled Trial

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2017

von Yoo, D. | Suh, C. | Shim, S. | +18

9

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10 : Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2017

von Park, W. | Suh, C. | Shim, S. | +17

10

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2017

von Yoo, D. | Suh, C. | Shim, S. | +18